Evidence map›Paper›PMID 38141073›Full record

ArticleArchives of microbiology2023

Assessment of the photoprotective potential and structural characterization of secondary metabolites of Antarctic fungus Arthrinium sp.

Ana Carolina Jordão, Gustavo Souza Dos Santos, Thaiz Rodrigues Teixeira, Ana Júlia Pasuch Gluzezak, Clarissa Bechuate de Souza Azevedo, Karina de Castro Pereira, Ludmilla Tonani, Lorena Rigo Gaspar, Márcia Regina von Zeska Kress, Pio Colepicolo and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Marine natural products.Natural product reports · 2026
    Review
  5. Article
  6. Article
  7. Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.JID innovations : skin science from molecules to population health · 2025
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Ana Carolina JordãoDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0001-8076-5967
Gustavo Souza Dos SantosDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-7288-2466
Thaiz Rodrigues TeixeiraDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0001-9514-3327
Ana Júlia Pasuch GluzezakDepartment of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0003-3383-5381
Clarissa Bechuate de Souza AzevedoDepartment of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-7296-6395
Karina de Castro PereiraDepartment of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Ludmilla TonaniDepartment of Clinical, Toxicological and Bromatological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0001-6892-8962
Lorena Rigo GasparDepartment of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-1550-3036
Márcia Regina von Zeska KressDepartment of Clinical, Toxicological and Bromatological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0003-1239-7722
Pio ColepicoloDepartment of Biochemistry, Chemistry Institute, University of São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-2334-1532
Hosana Maria DebonsiDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. hosana@fcfrp.usp.br.ORCID http://orcid.org/0000-0002-4888-0217
Universidade de São Paulo · BRUniversidade de Ribeirão Preto · BRUniversidade do Estado da Bahia · BR

Funding

National Institute of Science and Technology (INCT:BioNat) #465637/2014-0PROANTAR/MCTI/CNPq N°64/2013State of São Paulo Research Foundation (FAPESP) #2014/50926-0 and 2017/03552-5
6 · The paper itself

Abstract

Interest in Antarctic fungi has grown due to their resilience in harsh environments, suggesting the presence of valuable compounds from its organisms, such as those presenting photoprotective potential, since this environment suffers the most dangerous UV exposure in the world. Therefore, this research aimed to assess the photoprotective potential of compounds from sustainable marine sources, specifically seaweed-derived fungi from Antarctic continent. These studies led to discovery of photoprotective and antioxidant properties of metabolites from Arthrinium sp., an endophytic fungus from Antarctic brown algae Phaeurus antarcticus. From crude extract, fractions A-I were obtained and compounds 1-6 isolated from E and F fractions, namely 3-Hydroxybenzyl alcohol (1), (-)-orthosporin (2), norlichexanthone (3), anomalin B (4), anomalin A (5), and agonodepside B (6). Compounds 1, 2, and 6 were not previously reported in Arthrinium. Fraction F demonstrated excellent absorbance in both UVA and UVB regions, while compound 6 exhibited lower UVB absorbance, possibly due to synergistic effects. Fraction F and compound 6 displayed photostability and were non-phototoxic to HaCaT cells. They also exhibited antioxidant activity by reducing intracellular ROS production induced by UVA in keratinocyte monolayers and reconstructed human skin models (resulting in 34.6% and 30.2% fluorescence reduction) and did not show irritation potential in HET-CAM assay. Thus, both are promising candidates for use in sunscreens. It is noted that Fraction F does not require further purification, making it advantageous, although clinical studies are necessary to confirm its potential applicability for sunscreen formulations.

Indexed as

Ultraviolet RaysXylarialesAntioxidantsHumansSkinSunscreening AgentsAntioxidantsSunscreening AgentsAntioxidantArthriniumMarine Antarctic natural productsPhotoprotectionReconstructed human skin

Identifiers

PMID38141073
OpenAlexW4390144044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.